EMBioSys
Founded 2022
About EMBioSys
EMBioSys develops a platform of non-pharmacological therapeutics that utilize low level induced electric fields (iEF Therapy) for treatment of breast cancer. What makes our iEF Therapy unique is that we deploy it in the form of home-use, electrode-free, wearable garments. Our efficacy data has proven that iEF Therapy hinders metastasis, reduces the volume and weight of the primary tumor, improves the efficacy of chemotherapy, increases the host immune response, while selectively targeting only cancer cells.
Company Facts
- Founded: 2022
- Legal name: EMBioSys Inc.
- Operating status: Operating
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Website: embiosys.com
- Phone: 978-771-4662
Social Profiles
Canonical: https://fsome.com/organization/embiosys-8373715 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.